Immunostaining of human breast cancer tissue showing p38 when phosphorylated at Thr180/Tyr182 in red using p38 MAPK (phospho Thr180/Tyr182) antibody (GTX48614)
![Western Blot: 38MAPK Phosphospecific Antibody [GTX48614] - Western blot of C-6 glioma cell lysates that had been incubated in the absence (Control) or presence of anisomycin showing specific immunolabeling of the ~39k p38 MAPK protein phosphorylated at Thr180 and Tyr182.](https://www.genetex.com/upload/website/prouct_img/normal/GTX48614/p38-MAPK-phospho-Thr180-Tyr182-antibody-GTX48614-WB-1_w_23060823_326.webp "Western Blot: 38MAPK Phosphospecific Antibody [GTX48614] - Western blot of C-6 glioma cell lysates that had been incubated in the absence (Control) or presence of anisomycin showing specific immunolabeling of the ~39k p38 MAPK protein phosphorylated at Thr180 and Tyr182.")
Immunostaining of human breast cancer tissue showing p38 when phosphorylated at Thr180/Tyr182 in red using p38 MAPK (phospho Thr180/Tyr182) antibody (GTX48614)
p38 MAPK (phospho Thr180/Tyr182) antibody
GTX48614
ApplicationsWestern Blot, ImmunoHistoChemistry
Product group Antibodies
ReactivityHuman, Mouse, Rat
TargetMapk14
Overview
- SupplierGeneTex
- Product Namep38 MAPK (phospho Thr180/Tyr182) antibody
- Delivery Days Customer9
- Application Supplier NoteWe recommend the following starting dilutions: For WB: Use at a dilution of 1:1000. For IHC: Use a dilution of 1:250. Optimal dilutions/concentrations should be determined by the end user.
- ApplicationsWestern Blot, ImmunoHistoChemistry
- CertificationResearch Use Only
- ClonalityPolyclonal
- ConjugateUnconjugated
- FormulationLiquid
- Gene ID81649
- Target nameMapk14
- Target descriptionmitogen activated protein kinase 14
- Target synonymsCRK1; Csaids binding protein; CSBP; Csbp1; Csbp2; CSPB1; cytokine suppressive anti-inflammatory drug binding protein; cytokine-supressive anti-inflammatory drug binding protein; Exip; Hog; MAP kinase 14; MAP kinase 2; MAP kinase Mxi2; MAP kinase p38 alpha; MAPK 14; MAX-interacting protein 2; mitogen-activated protein kinase 14; mitogen-activated protein kinase 14A; mitogen-activated protein kinase p38 alpha; Mxi2; p38; p38 MAP kinase; p38 mitogen activated protein kinase; p38alpha; p38alpha Exip; p38Hog; Prkm14; Prkm15; reactive kinase; RK; Sapk2A; stress-activated protein kinase 2A
- HostRabbit
- IsotypeIgG
- Modification TypePhosphorylated
- Scientific Descriptionmitogen-activated protein kinase; involved in intracellular signalling, inhibition of apoptosis and gene activation [RGD, Feb 2006]
- ReactivityHuman, Mouse, Rat
- Storage Instruction-20°C or -80°C,2°C to 8°C
- UNSPSC12352203
References
- Dracorhodin perchlorate enhances wound healing via beta-catenin, ERK/p38, and AKT signaling in human HaCaT keratinocytes. Lu CC et al., 2021 Aug, Exp Ther MedRead more
- Next-generation sequencing analysis reveals that MTH-3, a novel curcuminoid derivative, suppresses the invasion of MDA-MB-231 triple-negative breast adenocarcinoma cells. Chiu YJ et al., 2021 Jul, Oncol RepRead more
- Metformin triggers the intrinsic apoptotic response in human AGS gastric adenocarcinoma cells by activating AMPK and suppressing mTOR/AKT signaling. Lu CC et al., 2019 Apr, Int J OncolRead more
- Synergistic inhibitory effects of cetuximab and curcumin on human cisplatin-resistant oral cancer CAR cells through intrinsic apoptotic process. Chen CF et al., 2018 Nov, Oncol LettRead more
- RRM2B-Mediated Regulation of Mitochondrial Activity and Inflammation under Oxidative Stress. Cho EC et al., 2015, Mediators InflammRead more
- The protective effects of spirulina in cyclophosphamide induced nephrotoxicity and urotoxicity in rats. Sinanoglu O et al., 2012 Dec, UrologyRead more
- Quercetin 3-O-methyl ether protects FL83B cells from copper induced oxidative stress through the PI3K/Akt and MAPK/Erk pathway. Tseng HL et al., 2012 Oct 1, Toxicol Appl PharmacolRead more